IGF1 and Alzheimer disease: This effect may be the result of the reduced serum-to-cerebrospinal fluid (CSF) traffic of IGF1 reported in both patients with AD (Johanssonet al, 2013) and AD mouse models (Trueba-Saizet al, 2013).